The post Fed Ends QT With $13.5B Liquidity Boost — Crypto Rally Ahead? appeared on BitcoinEthereumNews.com. Key Notes This is the US Fed’s second-largest liquidity operation since COVID-19. Fundstrat’s Tom Lee expects improved liquidity to benefit risk assets, projecting a potential Bitcoin rally to all-time highs by January 2026. However, market uncertainty remains as BOJ rate hike odds for December rise to 81%. By officially putting an end to the quantitative tightening (QT) on Dec. 1, the US Federal Reserve has initiated the first steps for liquidity expansion. Market experts see this as a stepping stone for the next major crypto rally. US Fed Injects $13.5 Billion in Banking System The US Federal Reserve injected $13.5 billion into the banking system through overnight repurchase agreements. This marks the second-largest single-day liquidity operation since the COVID-19 crisis. The move also exceeds the peak repo injections recorded during the Dot-Com bubble. US Fed Liquidity Injection | Source: Barchat The operation signals heightened short-term funding demand within the banking sector. This could ultimately bode well for risk-on assets such as US equities and even the crypto market. The Federal Reserve has officially halted its Quantitative Tightening program as of December 1, 2025, marking a notable shift in US monetary policy. The decision comes after the central bank withdrew approximately $2.4 trillion from the financial system since the tightening cycle began in June 2022. However, just ahead of the Fed officially ending QT, the crypto market faced a major pullback. Experts Remain Divided on What Happens Next in the Crypto Market Fundstrat’s Tom Lee said the Federal Reserve’s decision to halt quantitative tightening would be a turning point for the crypto market. Lee noted that the last time the Fed ended QT, markets rallied roughly 17% within three weeks. Moreover, Lee believes that this shift is particularly relevant for Bitcoin BTC $86 734 24h volatility: 0.0% Market cap: $1.73 T… The post Fed Ends QT With $13.5B Liquidity Boost — Crypto Rally Ahead? appeared on BitcoinEthereumNews.com. Key Notes This is the US Fed’s second-largest liquidity operation since COVID-19. Fundstrat’s Tom Lee expects improved liquidity to benefit risk assets, projecting a potential Bitcoin rally to all-time highs by January 2026. However, market uncertainty remains as BOJ rate hike odds for December rise to 81%. By officially putting an end to the quantitative tightening (QT) on Dec. 1, the US Federal Reserve has initiated the first steps for liquidity expansion. Market experts see this as a stepping stone for the next major crypto rally. US Fed Injects $13.5 Billion in Banking System The US Federal Reserve injected $13.5 billion into the banking system through overnight repurchase agreements. This marks the second-largest single-day liquidity operation since the COVID-19 crisis. The move also exceeds the peak repo injections recorded during the Dot-Com bubble. US Fed Liquidity Injection | Source: Barchat The operation signals heightened short-term funding demand within the banking sector. This could ultimately bode well for risk-on assets such as US equities and even the crypto market. The Federal Reserve has officially halted its Quantitative Tightening program as of December 1, 2025, marking a notable shift in US monetary policy. The decision comes after the central bank withdrew approximately $2.4 trillion from the financial system since the tightening cycle began in June 2022. However, just ahead of the Fed officially ending QT, the crypto market faced a major pullback. Experts Remain Divided on What Happens Next in the Crypto Market Fundstrat’s Tom Lee said the Federal Reserve’s decision to halt quantitative tightening would be a turning point for the crypto market. Lee noted that the last time the Fed ended QT, markets rallied roughly 17% within three weeks. Moreover, Lee believes that this shift is particularly relevant for Bitcoin BTC $86 734 24h volatility: 0.0% Market cap: $1.73 T…

Fed Ends QT With $13.5B Liquidity Boost — Crypto Rally Ahead?

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Notes

  • This is the US Fed’s second-largest liquidity operation since COVID-19.
  • Fundstrat’s Tom Lee expects improved liquidity to benefit risk assets, projecting a potential Bitcoin rally to all-time highs by January 2026.
  • However, market uncertainty remains as BOJ rate hike odds for December rise to 81%.

By officially putting an end to the quantitative tightening (QT) on Dec. 1, the US Federal Reserve has initiated the first steps for liquidity expansion. Market experts see this as a stepping stone for the next major crypto rally.

US Fed Injects $13.5 Billion in Banking System

The US Federal Reserve injected $13.5 billion into the banking system through overnight repurchase agreements. This marks the second-largest single-day liquidity operation since the COVID-19 crisis. The move also exceeds the peak repo injections recorded during the Dot-Com bubble.


US Fed Liquidity Injection | Source: Barchat

The operation signals heightened short-term funding demand within the banking sector. This could ultimately bode well for risk-on assets such as US equities and even the crypto market.

The Federal Reserve has officially halted its Quantitative Tightening program as of December 1, 2025, marking a notable shift in US monetary policy. The decision comes after the central bank withdrew approximately $2.4 trillion from the financial system since the tightening cycle began in June 2022. However, just ahead of the Fed officially ending QT, the crypto market faced a major pullback.

Experts Remain Divided on What Happens Next in the Crypto Market

Fundstrat’s Tom Lee said the Federal Reserve’s decision to halt quantitative tightening would be a turning point for the crypto market. Lee noted that the last time the Fed ended QT, markets rallied roughly 17% within three weeks.

Moreover, Lee believes that this shift is particularly relevant for Bitcoin


BTC
$86 734



24h volatility:
0.0%


Market cap:
$1.73 T



Vol. 24h:
$75.04 B

, as improved liquidity historically supports stronger performance in risk assets. He expects market conditions to strengthen into year-end and is projecting a potential new Bitcoin all-time high by late January.

Following the end of QT, everyone is eagerly eyeing the Fed rate cuts scheduled ahead during the December FOMC. But on the other hand, market analyst Ted Pillows noted that the probability of a Bank of Japan (BOJ) rate hike at the December meeting has climbed to 81%.

The BOJ has raised rates three times in the current tightening cycle, in March 2024, July 2024, and most recently in January 2025. Pillows highlighted that each of these rate hikes was followed by a broad selloff in Bitcoin and the wider crypto market.

next

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Cryptocurrency News, News


Bhushan is a FinTech enthusiast and holds a good flair in understanding financial markets. His interest in economics and finance draw his attention towards the new emerging Blockchain Technology and Cryptocurrency markets. He is continuously in a learning process and keeps himself motivated by sharing his acquired knowledge. In free time he reads thriller fictions novels and sometimes explore his culinary skills.

Bhushan Akolkar on X

Source: https://www.coinspeaker.com/us-fed-ends-qt-with-13-5-billion-liquidity-pump-crypto-market-rally-ahead/

Market Opportunity
TOMCoin Logo
TOMCoin Price(TOM)
$0,00006988
$0,00006988$0,00006988
+2,59%
USD
TOMCoin (TOM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26